Table 3.
Characteristics and serologic marker details of the patients with loss of antibody
| Patients No. | Age (yr) | Gender |
Antibody disappearance time (post-transplantation months) |
Time of antibody reappearance (mo) | Disease | |
| Anti-HBs | Anti-HBc | |||||
| #1 | 71 | F | +6 | - | +18 | MM |
| #6 | 59 | F | +6 | - | - | MM |
| #8 | 50 | M | +12 | - | +18 | MM |
| #10 | 48 | F | +9 | - | - | MM |
| #12 | 52 | F | +24 | +6 | - | MM |
| #27 | 46 | F | +1 | - | +12 | MM |
| #28 | 59 | M | +1 | - | +8 | MM |
| #39 | 59 | M | +1 | - | - | MM |
| #40 | 30 | M | - | +1 | +6 | NHL |
| #41 | 68 | M | - | +3 | - | MM |
| #43 | 16 | F | +1 | - | - | PNET |
| #48 | 56 | F | +1 | +1 | +6 (anti-HBc) | MM |
| #55 | 64 | M | +6 | - | - | MM |
| #89 | 23 | F | +3 | - | - | HD |
MM: Multiple myeloma; NHL: Non-Hodgkin’s lymphoma; PNET: Primitive neuroectodermal tumor.